The role of genetic polymorphism and other factors on clopidogrel resistance (CR) in an Asian population with coronary heart disease (CHD)
Clopidogrel is a widely-used antiplatelet drug. It is important for the treatment and prevention of coronary heart disease. Clopidogrel can effectively reduce platelet activity and therefore reduce stent thrombosis. However, some patients still have ischemic events despite taking the clopidogrel due...
Saved in:
Main Authors: | Akkaif, Mohammed Ahmed, Daud, Nur Aizati Athirah, Sha'aban, Abubakar, Ng, Mei Li, Abdul Kader, Muhamad Ali Sk, Noor, Dzul Azri Mohamed, Ibrahim, Baharudin |
---|---|
Format: | Article |
Published: |
MDPI
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/28823/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coronary Heart Disease (CHD) in elderly patients: Which drug to choose, ticagrelor and clopidogrel? a systematic review and meta-analysis of randomized controlled trials
by: Akkaif, Mohammed Ahmed, et al.
Published: (2021) -
Knowledge, awareness and perception of coronary heart disease (CHD) among residents in Kuantan.
by: Thandar Soe, Sumaiyah Jamaludin, et al.
Published: (2018) -
D-Exercise for patients with Coronary Heart Disease (CHD) / Norfidah Mohamad … [et al.]
by: Mohamad, Norfidah, et al.
Published: (2014) -
Knowledge, awareness, and perception of coronary heart disease (CHD) among residents in Kuantan, Pahang, Malaysia
by: Jamaludin, Thandar Soe Sumaiyah, et al.
Published: (2019) -
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017)